Detalles de la búsqueda
1.
Prediction of severe infections in chronic lymphocytic leukemia: a simple risk score to stratify patients at diagnosis.
Ann Hematol
; 103(5): 1655-1664, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38236391
2.
Ruxolitinib does not impair humoral immune response to COVID-19 vaccination with BNT162b2 mRNA COVID-19 vaccine in patients with myelofibrosis.
Ann Hematol
; 101(4): 929-931, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34302519
3.
Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vulnerability during the Omicron Pandemic in Patients with CLL: Two-Year Follow-Up of a Multicenter Study.
Cancers (Basel)
; 15(11)2023 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37296954
4.
Patients with Chronic Lymphocytic Leukemia Have a Very High Risk of Ineffective Response to the BNT162b2 Vaccine.
Vaccines (Basel)
; 10(7)2022 Jul 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35891328
Resultados
1 -
4
de 4
1
Próxima >
>>